[MSF] New York/Geneva -- The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes Johnson & Johnson's (J&J) announcement today to reduce the price of its tuberculosis (TB) drug bedaquiline to $1.50 per day. Governments must now urgently scale up the use of the treatment as a core part of drug-resistant TB (DR-TB) regimens, MSF said.